Cardiff Oncology (NASDAQ:CRDF) , a clinical-stage biotech company specializing in new cancer treatments, saw its share price rise as high as $7.18 on Monday. It closed the day at $6.74, up about 7% from its previous close.
Itron, Inc. (NASDAQ:ITRI) has earned a consensus recommendation of "Buy" from the ten brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, six have assigned a buy recommendatio
Asbury Automotive Group, Inc. (NYSE:ABG) has been given an average rating of “Buy” by the eight ratings firms that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $191.00.
Separately, Morgan Stanley boosted their target price on Asbury Automotive Group from $201.00 to $205.00 and gave the company an “equal weight”....More>>>
Loomis Sayles & Co. L P cut its holdings in Signature Bank (NASDAQ:SBNY) by 9.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 218,550 shares of the bank’s stock after selling 22,927 shares during the period. Loomis Sayles & Co. L P’s holdings in Signature Bank were worth $31,023,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of SBNY. BlackRock Inc. increased its holdings in shares of Signature Bank by 2.2% during the 1st quarter.....More>>>
With the rapid spread of the highly contagious Delta variant of the coronavirus, Hawaiian Holdings (HA Quick QuoteHA ) recently trimmed its outlook for the third quarter of 2021. This bearish view adds to the carrier’s woes, shares of which have declined 29.1% over the past three
Assurant, Inc. (AIZ Quick QuoteAIZ ) has been favored by investors on the back of continued organic growth across distribution channels, inorganic and organic growth strategies and effective capital deployment.
HealthEquity, Inc. (NASDAQ:HQY) – Equities researchers at KeyCorp increased their Q3 2022 earnings per share (EPS) estimates for shares of HealthEquity in a research note issued to investors on Wednesday, September 8th. KeyCorp analyst D. Hooker now anticipates that the company